Found: 12
Select item for more details and to access through your institution.
αvβ3 Integrin Expression and Mitogenic Effects by Thyroid Hormones in Chronic Lymphocytic Leukemia.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 8, p. 1766, doi. 10.3390/jcm10081766
- By:
- Publication type:
- Article
Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/ CT is beneficial: a prospective multicentre trial of 355 patients.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 5, p. 709, doi. 10.1111/bjh.14734
- By:
- Publication type:
- Article
Prolonged Blood Storage Does Not Effect Survival in an Animal Model of Hemorrhagic Shock.
- Published in:
- Transfusion Medicine & Hemotherapy, 2011, v. 38, n. 4, p. 272, doi. 10.1159/000330483
- By:
- Publication type:
- Article
Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma—a real-world multicenter retrospective cohort study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2127, doi. 10.1007/s00277-023-05306-2
- By:
- Publication type:
- Article
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
ABCL-366: Mosunetuzumab (Mosun) Monotherapy for Elderly/Unfit Patients with First-Line Diffuse Large B-Cell Lymphoma (DLBCL) Continues to Show Promising Safety and Efficacy with Durable Complete Responses.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S395, doi. 10.1016/S2152-2650(21)01896-6
- By:
- Publication type:
- Article
Poster: ABCL-366: Mosunetuzumab (Mosun) Monotherapy for Elderly/Unfit Patients with First-Line Diffuse Large B-Cell Lymphoma (DLBCL) Continues to Show Promising Safety and Efficacy with Durable Complete Responses.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S239, doi. 10.1016/S2152-2650(21)01501-9
- By:
- Publication type:
- Article
Hemophagocytic Lymphohistiocytosis as the Presenting Symptom of Aggressive Lymphoma - A Case Series and Review of the Literature.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S271, doi. 10.1016/j.clml.2018.07.193
- By:
- Publication type:
- Article
Hemophagocytic lymphohistiocytosis as a harbinger of aggressive lymphoma: a case series.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Nuclear αvβ3 integrin expression, post translational modifications and regulation in hematological malignancies.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 1, p. 72, doi. 10.1002/hon.2927
- By:
- Publication type:
- Article
Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Immune Thrombocytopenia: Recent Progress in Pathophysiology and Treatment.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2015, v. 21, n. 5, p. 397, doi. 10.1177/1076029614526639
- By:
- Publication type:
- Article